Another research found the direct regulation relationship between miRNA-222 and KIT in imatinib-resistant GIST cells whose proliferation ability was inhibited by miRNA-222 (Gits et al., 2013). This evidence concerns the gene KIT and gastrointestinal stromal tumor.